Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy — Carla Zoja (2015) | RDL Network
Dick de Zeeuw, Giuseppe Remuzzi, Hans‐Henrik Parving, William F. Keane, Zhongxin Zhang, Shahnaz Shahinfar, Steve Snapinn, Mark E. Cooper, William E. Mitch, Barry M. Brenner
Wouter B.A. Eijkelkamp, Zhongxin Zhang, Giuseppe Remuzzi, Hans‐Henrik Parving, Mark E. Cooper, William F. Keane, Shahnaz Shahinfar, Gilbert W. Gleim, Barry M. Brenner, Dick de Zeeuw
Dick de Zeeuw, Blai Coll, Dennis L. Andress, John J. Brennan, Hui Tang, Mark T. Houser, Ricardo Correa‐Rotter, Donald E. Kohan, Hiddo J.L. Heerspink, Hirofumi Makino, Vlado Perkovic, Yili Pritchett, Giuseppe Remuzzi, Sheldon W. Tobe, Robert Toto, Giancarlo Viberti, Hans‐Henrik Parving
Liffert Vogt, Carlos Chiurchiu, Harbajan Chadha‐Boreham, Parisa Danaietash, Jasper Dingemanse, Samy Hadjadj, Henry Krum, Gerjan Navis, Eric Neuhart, Aneliya Parvanova, Piero Ruggenenti, A. J. J. Woittiez, Reuven Zimlichman, Giuseppe Remuzzi, Dick de Zeeuw
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.